HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

INTERMEDIATE ENDEMICITY OF HEPATITIS A VIRUS INFECTION IN RURAL SETTLEMENT PROJECTS OF SOUTHWEST GOIÁS, BRAZIL.

AbstractBACKGROUND:
Rural populations present an elevated risk of exposure to hepatitis A virus.
OBJECTIVE:
The objective of this study was to estimate the prevalence and risk factors associated with hepatitis A virus infection among residents of rural settlement projects of southwest Goiás, Central Brazil.
METHODS:
A total of 466 residents were interviewed and tested for the detection of anti- hepatitis A virus antibodies by ELISA.
RESULTS:
The global prevalence of anti- hepatitis A virus was 82.2%. In individuals aged 5-9 years and 10-19 years, the prevalence was 15% and 58.8%, respectively. Persons in the 10-19 age group, with a history of life in encampments, with more than five people per residence consuming well water, were predictors for exposure to hepatitis A virus.
CONCLUSION:
Our results suggest that the hepatitis A virus endemicity in rural settlements in southwest Goiás similar to that found in the urban population of the Midwest Region, confirming the implementation of universal hepatitis A vaccination in children.
AuthorsRaquel Silva Pinheiro, Lyriane Apolinário de Araújo, Karlla Antonieta Amorim Caetano, Marcos André de Matos, Megmar Aparecida dos Santos Carneiro, Sheila Araújo Teles
JournalArquivos de gastroenterologia (Arq Gastroenterol) Vol. 52 Issue 3 Pg. 200-3 ( 2015) ISSN: 1678-4219 [Electronic] Brazil
PMID26486287 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Brazil (epidemiology)
  • Child
  • Child, Preschool
  • Endemic Diseases
  • Female
  • Hepatitis A (epidemiology, virology)
  • Hepatitis A Virus, Human
  • Humans
  • Male
  • Prevalence
  • Risk Factors
  • Rural Population (statistics & numerical data)
  • Surveys and Questionnaires
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: